Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Field

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
European Heart Journal. Imaging Methods and Practice|July 11, 2025
Estimation of toe brachial index based on forefoot Doppler waveformsAlexander D Rodway, Rachael Jarrett, Darren Cheal, et al.
Autophagy|March 10, 2025
The mitophagy receptor BNIP3L/Nix coordinates nuclear calcium signaling to modulate the muscle phenotypeJared T Field, Donald Chapman, Yan Hai, et al.
Journal of Clinical Medicine|January 8, 2023
Ankle Doppler for Cuffless Ankle Brachial Index Estimation and Peripheral Artery Disease Diagnosis Independent of DiabetesAlexander D Rodway, Darren Cheal, Charlotte Allan, et al.
Bone Marrow Transplantation|June 23, 2009
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantationT Field, J Perkins, Y Huang, et al.
International Journal of Obesity (2005)|June 10, 2010
Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodentsY-L Liu, H E Ford, M R Druce, et al.
Diabetes|April 2, 2010
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humansBenjamin C T Field, Alison M Wren, Veronique Peters, et al.
Endocrinology|December 17, 2008
Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogsMaralyn R Druce, James S Minnion, Benjamin C T Field, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
Endocrinology|September 29, 2011
A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36Melisande L Addison, James S Minnion, Joy C Shillito, et al.
Bone Marrow Transplantation|December 7, 2010
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomesJ Perkins, T Field, J Kim, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
European Heart Journal. Imaging Methods and Practice|July 11, 2025
Estimation of toe brachial index based on forefoot Doppler waveformsAlexander D Rodway, Rachael Jarrett, Darren Cheal, et al.
Autophagy|March 10, 2025
The mitophagy receptor BNIP3L/Nix coordinates nuclear calcium signaling to modulate the muscle phenotypeJared T Field, Donald Chapman, Yan Hai, et al.
Journal of Clinical Medicine|January 8, 2023
Ankle Doppler for Cuffless Ankle Brachial Index Estimation and Peripheral Artery Disease Diagnosis Independent of DiabetesAlexander D Rodway, Darren Cheal, Charlotte Allan, et al.
Bone Marrow Transplantation|June 23, 2009
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantationT Field, J Perkins, Y Huang, et al.
International Journal of Obesity (2005)|June 10, 2010
Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodentsY-L Liu, H E Ford, M R Druce, et al.
Diabetes|April 2, 2010
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humansBenjamin C T Field, Alison M Wren, Veronique Peters, et al.
Endocrinology|December 17, 2008
Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogsMaralyn R Druce, James S Minnion, Benjamin C T Field, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 1, 2022
Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods StudySimon de Lusignan, Andrew McGovern, William Hinton, et al.
Endocrinology|September 29, 2011
A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36Melisande L Addison, James S Minnion, Joy C Shillito, et al.
Bone Marrow Transplantation|December 7, 2010
Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomesJ Perkins, T Field, J Kim, et al.
Pageof 23